Bone elongation in rats with renal failure and mild or advanced secondary hyperparathyroidism.

BACKGROUND Impairment of growth in children with chronic renal failure may be due, in part to the insensitivity to the actions of growth hormone by insulin-like growth factor-I (IGF-I) because of accumulations of IGF binding proteins. There are a few studies describing the changes that occur in the growth plate in renal failure. None of these studies has simultaneously compared the modifications in the expression of selected markers of endochondral bone formation in renal failure with mild or advanced secondary hyperparathyroidism. METHODS Forty-six rats that underwent 5/6 nephrectomy (Nx) were fed either standard rodent diet (Nx-control) or high phosphorus diet to induce advanced secondary hyperparathyroidism (Nx-phosphorus) for 4 weeks. Sections of the tibia were obtained for growth plate histomorphometry, immunohistochemistry studies, and in situ hybridization experiments for selected markers of endochondral bone formation. RESULTS Weight gain, gain in length, and tibial length were less in Nx animals. Serum parathyroid hormone (PTH) and phosphorus levels were higher and serum calcium levels were lower in the Nx-phosphorus group. The width of the growth plate was much shorter in the Nx-phosphorus group due to a decrease in both proliferative and hypertrophic zones. IGF-I protein and IGF binding protein-3 staining were diminished in both Nx groups without changes in the IGF-I receptor expression; the decline in IGF-I protein expression was much lower in the Nx-phosphorus group. PTH/PTH receptor protein (PTHrP) receptor mRNA transcripts decline and tartrate-resistant acid phosphastase (TRAP) staining increased only in the Nx-phosphorus group. CONCLUSION The growth impairment in renal failure may be worsened by the severity of secondary hyperparathyroidism.

[1]  B. Tönshoff,et al.  Growth hormone resistance and inhibition of somatomedin activity by excess of insulin-like growth factor binding protein in uraemia , 1991, Pediatric Nephrology.

[2]  D. Haffner,et al.  Short dialyzed children respond less to growth hormone than patients prior to dialysis , 1996, Pediatric Nephrology.

[3]  R. Fine,et al.  Recombinant human growth hormone in infants and young children with chronic renal insufficiency , 1995, Pediatric Nephrology.

[4]  N. Koszewski,et al.  Administration of PTH-(7-84) antagonizes the effects of PTH-(1-84) on bone in rats with moderate renal failure. , 2003, Endocrinology.

[5]  C. Sanchez,et al.  Effects of thyroparathyroidectomy, exogenous calcium, and short-term calcitriol therapy on the growth plate in renal failure. , 2003, Journal of the American Society of Nephrology : JASN.

[6]  S. Majumdar,et al.  Insulin‐Like Growth Factor I Is Required for the Anabolic Actions of Parathyroid Hormone on Mouse Bone , 2002, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[7]  B. Lanske,et al.  PTHrP and Indian hedgehog control differentiation of growth plate chondrocytes at multiple steps. , 2002, Development.

[8]  C. Sanchez,et al.  Alterations in the growth plate cartilage of rats with renal failure receiving corticosteroid therapy. , 2002, Bone.

[9]  F. R. Bringhurst,et al.  Human PTH-(7-84) Inhibits Bone Resorption in Vitro Via Actions Independent of the Type 1 PTH/PTHrP Receptor. , 2002, Endocrinology.

[10]  S. Mohan,et al.  Intact IGF-binding protein-4 and -5 and their respective fragments isolated from chronic renal failure serum differentially modulate IGF-I actions in cultured growth plate chondrocytes. , 2001, Journal of the American Society of Nephrology : JASN.

[11]  C. Farquharson,et al.  Printed in U.S.A. Copyright © 2001 by The Endocrine Society Regulation of Chondrocyte Terminal Differentiation in the Postembryonic Growth Plate: The Role of the PTHrP-Indian Hedgehog Axis , 2022 .

[12]  P. Backeljauw,et al.  Therapy for 6.5-7.5 years with recombinant insulin-like growth factor I in children with growth hormone insensitivity syndrome: a clinical research center study. , 2001, The Journal of clinical endocrinology and metabolism.

[13]  M. Balbín,et al.  Collagen Metabolism Is Markedly Altered in the Hypertrophic Cartilage of Growth Plates from Rats with Growth Impairment Secondary to Chronic Renal Failure , 2001, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[14]  A. McMahon,et al.  Indian hedgehog couples chondrogenesis to osteogenesis in endochondral bone development. , 2001, The Journal of clinical investigation.

[15]  M. Pańczyk-Tomaszewska,et al.  Vitamin D metabolite requirements in dialysed children receiving recombinant human growth hormone. , 2000, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[16]  C. Bondy,et al.  Igf1 promotes longitudinal bone growth by insulin‐like actions augmenting chondrocyte hypertrophy , 1999, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[17]  R. Baron,et al.  Ablation of the PTHrP gene or the PTH/PTHrP receptor gene leads to distinct abnormalities in bone development. , 1999, The Journal of clinical investigation.

[18]  A. Harvey,et al.  Parathyroid Hormone-(1–34) Enhances Aggrecan Synthesis via an Insulin-like Growth Factor-I Pathway* , 1999, The Journal of Biological Chemistry.

[19]  F. Santos,et al.  Growth plate cartilage formation and resorption are differentially depressed in growth retarded uremic rats. , 1999, Journal of the American Society of Nephrology : JASN.

[20]  H. Jüppner,et al.  Growth of long bones in renal failure: roles of hyperparathyroidism, growth hormone and calcitriol. , 1998, Kidney international.

[21]  D. Powell,et al.  Decreased Hepatic Insulin-Like Growth Factor (IGF)-I and Increased IGF Binding Protein-1 and -2 Gene Expression in Experimental Uremia. , 1997, Endocrinology.

[22]  Ellen M. Leiferman,et al.  Differential growth by growth plates as a function of multiple parameters of chondrocytic kinetics , 1996, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.

[23]  Aníbal Ferreira,et al.  PTH/PTHrP receptor mRNA is down-regulated in epiphyseal cartilage growth plate of uraemic rats , 1996 .

[24]  Clifford J. Tabin,et al.  Regulation of Rate of Cartilage Differentiation by Indian Hedgehog and PTH-Related Protein , 1996, Science.

[25]  B. Lanske,et al.  PTH/PTHrP Receptor in Early Development and Indian Hedgehog--Regulated Bone Growth , 1996, Science.

[26]  B. Tönshoff,et al.  Growth promoting effects of growth hormone and IGF-I are additive in experimental uremia. , 1996, Kidney international.

[27]  V. Han,et al.  Insulin-like growth factor-I gene expression in the tibial epiphyseal growth plate of growth hormone-treated uremic rats. , 1995, Kidney international.

[28]  N. Amizuka,et al.  Parathyroid hormone-related peptide-depleted mice show abnormal epiphyseal cartilage development and altered endochondral bone formation , 1994, The Journal of cell biology.

[29]  E. Hunziker Mechanism of longitudinal bone growth and its regulation by growth plate chondrocytes , 1994, Microscopy research and technique.

[30]  R. Fine,et al.  Growth after recombinant human growth hormone treatment in children with chronic renal failure: report of a multicenter randomized double-blind placebo-controlled study. Genentech Cooperative Study Group. , 1994, The Journal of pediatrics.

[31]  H. Jüppner,et al.  In situ localization of PTH/PTHrP receptor mRNA in the bone of fetal and young rats. , 1992, Bone.

[32]  S. Mohan,et al.  1,25-Dihydroxyvitamin D3 differentially regulates the production of insulin-like growth factor I (IGF-I) and IGF-binding protein-4 in mouse osteoblasts. , 1991, Endocrinology.

[33]  G. Breur,et al.  Linear relationship between the volume of hypertrophic chondrocytes and the rate of longitudinal bone growth in growth plates , 1991, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.

[34]  M. Silbermann,et al.  The effect of 1,25-dihydroxyvitamin D3 on cartilage growth in neonatal mice. , 1983, Metabolic bone disease & related research.

[35]  H. Wesch,et al.  Skeletal changes and growth in experimental uremia. , 1977, Nephron.